Reducing binge eating behavior in rats using the novel ghrelin receptor antagonist agrelax



Cite item

Full Text

Abstract

Relevance. Binge eating disorder is the most common eating disorder, characterized by recurrent episodes of binge eating during which a person consumes excessive amounts of food in the absence of hunger. These episodes of binge eating are usually accompanied by a feeling of lack of control with an inability to refrain from eating or stop eating once it has started. A rodent model of binge eating disorder shows that intermittent consumption of energy-dense foods induces binge eating behavior independent of weight gain.

Aim. To study the effect of the ghrelin receptor antagonist Agrelax on compulsive overeating in rats.

Materials and methods. The study involved 30 male Wistar rats. To model compulsive overeating, animals received high-calorie food (a mixture based on Nutella spread) 3 times a week while maintaining free access to standard pelleted food and water. Compulsivity in behavior was assessed using the pellet burying test. The ghrelin receptor antagonist Agrelax was administered intranasally, 1 µg/1 µl, 10 µl in each nostril for 7 days.

Results. Compulsive behavior was assessed using the pellet burying test. The experimental group of animals receiving a high-calorie diet buried a significantly larger number of pellets than the control group (p<0.01). After a 7-day course of Agrelax, the number of buried balls decreased significantly, reaching the values of the control group (p<0.05). A technique for compulsive overeating in rats was developed by giving high-calorie food 3 times a week. After a 7-day course of Agrelax, the consumption of high-calorie foods significantly decreased (p<0.05). The daily consumption of standard feed in the group did not differ compared to the control group. However, after the course of Agrelax administration, the consumption of standard feed decreased.

Conclusion. The data obtained suggest new ways of synthesizing peptide pharmacological agents based on ghrelin and its antagonists for the correction of food addiction.

Full Text

Restricted Access

About the authors

Natalia Dvitrievna Nadbitova

FEDERAL STATE BUDGETARY SCIENTIFIC INSTITUTION INSTITUTE OF EXPERIMENTAL MEDICINE

Author for correspondence.
Email: natali_805@mail.ru
ORCID iD: 0000-0002-2957-226X
SPIN-code: 4153-1270
Scopus Author ID: 57732629300
ResearcherId: JBS-0803-2023

Researcher at the S.V.Anichkov Department of Neuropharmacology
Russian Federation, 197022, Saint-Petersburg 12, Acad. Pavlov Street

References

  1. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat. Neurosci.2010;13(5):635-41. doi: 10.1038/nn.2519.
  2. Association A.P., Diagnostic and statistical manual of mental disorders: DSM-5-TR, (No Title) (2013).
  3. Boggiano MM, Artiga AI, Pritchett CE et al. High intake of palatable food predicts binge-eating independent of susceptibility to obesity: An animal model of lean vs obese binge-eating and obesity with and without binge-eating. Int JObes. 2007;31(9):1357–1367. doi: 10.1038/sj.ijo.0803614
  4. Corwin RL, Wojnicki F.H.E. Binge Eating in Rats with Limited Access to Vegetable Shortening. Current Protocols in Neuroscience, 2006;36:9.23B.1-9.23B.11. doi. 10.1002/0471142301.ns0923bs36
  5. DiLeone RJ, Georgescu D, Nestler EJ Lateral hypothalamic neuropeptides in reward and drug addiction. Life. Sci. 2003;73:759 –768. doi: 10.1016/s0024-3205(03)00408-9
  6. Lutter M, Nestler EJ. Homeostatic and hedonic signals interact in the regulation of food intake. J Nutr. 2009;139:629 – 632. doi: 10.3945/jn.108.097618
  7. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat. Neurosci. 2010;13:635–641. doi: 10.1038/nn.2519
  8. Colantuoni C, Schwenker J, McCarthy J et al. Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport. 2001;12(16):3549-52. doi: 10.1097/00001756-200111160-00035
  9. Lenoir M, Serre F, Cantin L, Ahmed SH. Intense sweetness surpasses cocaine reward. PLoS ONE. 2007;2(8):e698. doi: 10.1371/journal.pone.0000698
  10. Heo YA, Duggan ST. Lisdexamfetamine: a review in binge eating disorder. CNS Drugs. 2017;31(11):1015–1022. doi: 10.1007/s40263-017-0477-1
  11. Ward K, Citrome L. Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder. Expert Opin. Drug Metab. Toxicol. 2018;14(2):229–238. doi: 10.1080/17425255.2018.1420163
  12. Chen CY, Asakawa M, Fujimiya et al. Ghrelin Gene Products and the Regulation of Food Intake and Gut Motility. Pharmacological Reviews. 2009;61(4):430–481. doi: 10.1124/pr.109.001958
  13. Lebedev AA, Karpova IV, Bychkov ER et al. The ghrelin antagonist [D-LYS3]-GHRP-6 decreases signs of risk behavior in a model of gambling addiction in rats by altering dopamine and serotonin metabolism. Neuroscience and Behavioral Physiology. 2022;52(3): 415-421. doi: 10.19163/MedChemRussia2021-2021-259
  14. Nass R, Pezzoli SS, Oliveriet MC al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: A randomized trial. Annals of Internal Medicine. 2008;149(9):601– 611. doi: 10.7326/0003-4819-149-9-200811040-00003
  15. Huda MSB, Dovey T, Wong SP et al. Ghrelin restores “lean-type” hunger and energy expenditure profiles in morbidly obese subjects but has no effect on postgastrectomy subjects. International Journal of Obesity. 2009; 33(3):317–325. doi: 10.1038/ijo.2008.270
  16. Broglio F, Arvat E, Benso A et al. Ghrelin, a natural gh secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. Journal of Clinical Endocrinology and Metabolism. 2001; 86(10): 5083–5086. doi: 10.1210/jcem.86.10.8098
  17. Reimer MK, Reimer G, Pacini B. Ahrén Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology. 2003;144(3): 916–921.
  18. Ducharme R, Anisman H, Abizaid A. Altered metabolic and neurochemical responses to chronic unpredictable stressors in ghrelin receptor-deficient mice. Eur J Neurosci. 2010; 32: 632–639. doi: 10.1111/j.1460-9568.2010.07310.x
  19. Geliebter A, Marci EG, Sami AH. Plasma ghrelin concentrations are lower in binge-eating disorder.J Nutr. 2005;135(5):1326-1330. doi: 10.1093/jn/135.5.1326.
  20. Piccoli L, Micioni Di Bonaventura MV, Cifani C et al. Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats. Neuropsychopharmacology.2012; 37(9):1999-2011. doi: 10.1038/npp.2012.48
  21. Lebedev AA, Purveev SS, Nadbitona ND et al. Reduction of compulsive overeating in rats caused by early maternal deprivation using a new ghrelin receptor antagonist agrelax. Reviews on clinical pharmacology and drug therapy. 2023;21(3): 255-262. (In Russ) doi: 10.17816/RCF562841
  22. Alvarez-Crespo M, Skibicka KP, Farkas I et al. The amygdala as a neurobiological target for ghrelin in rats: neuroanatomical, electrophysiological and behavioral evidence. PloS one. 2012;7(10):e46321. https://doi.org/10.1371/journal.pone.0046321
  23. Craft RM, Howard JL, Pollard GT. Conditioned defensive burying as a model for identifying anxiolytics. Pharmacol Biochem Behav. 1988;30(3):775-780. doi: 10.1016/0091-3057(88)90098-6.
  24. Kalinina T, Kudryashov N, Naplekova P et al. P.1.h.032 Interaction of antidepressants with mild chronic stress: behavioural effects and content of monoamines and their metabolites in mouse brain. Eur Neuropsy-chopharmacol. 2014;24:S288. doi: 10.1016/s0924-977x(14)70455-9
  25. Naumenko VS, Bazovkina DV, Semenova AA et al. Effect of glial cell line-derived neurotrophic factor on behaviorand key members of the brain serotonin system in mouse strains genetically predisposed to behavioral disorders. J Neurosci Res. 2013;91(12):1628-1638. doi: 10.1002/jnr.23286
  26. Yakushina ND, Tissen IU, Lebedev AA et al. The effect of intranasally administered ghrelin on the manifestations of compulsive behavior and the level of anxiety in rats after vital stress exposure. Reviews on clinical pharmacology and drug therapy. 2017;15(3): 28-37. (In Russ) doi: 10.17816/RCF15328-37
  27. Veale D, Roberts A. Obsessive-compulsive disorder. Biomed J. 2014;348:2183. doi: 10.1136/bmj.g2183.
  28. Lebedev AA, Yakushina ND, Pshenichnaya AG, Bychkov ER. Modeling of obsessive-compulsive and addictive gaming behavior in rats by administration of phenamine in the pellet burying test. Narcologi. 2017;16(181): 32–38. (In Russ)
  29. Naumenko VS, Bazovkina DV, Semenova AA et al. Effect of glial cell line-derived neurotrophic factor on behavior and key members of the brain serotonin system in mouse strains genetically predisposed to to behavioraldisorders. J Neurosci Res. 2013;91(12):1628-1638. doi:
  30. 1002/jnr.23286
  31. Shabanov PD, Lebedev AA, Yakushina ND. The effect of phenamine on the behavioral components of obsessive-compulsive and addictive gaming behavior in the marble burying test in rats. Reviews on clinical pharmacology and drug therapy. 2016; 14(3): 46–52. (In Russ)
  32. Decloedt EH, Stein DJ. Current trends in drug treatment of obsessive-compulsive disorder. Neuropsychiatr Dis Treat. 2010;6:233-42. doi: 10.2147/NDT.S3149
  33. Shabanov PD, Yakushina ND Lebedev AA. Pharmacology of peptide mechanisms of play behavior in rats. Drug addiction issues. 2020;4(187): 24-44. (In Russ) doi: 10.47877/0234-0623_2020_4_24
  34. Gnanapavan S, Kola B, Bustin SA et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metabolism. 2002; 87: 2988. doi: 10.1210/jcem.87.6.8739
  35. Carroll ME, France CP, Meisch RA at al. Food deprivation increases oral and intravenous drug intake in rats. Science. 1979;205(4 403):319–321. doi: 10.1126/science.36665
  36. Kharbanda KK, Farokhnia M, Deschaine SL at al. Role of the ghrelin system in alcohol use disorder and alcohol-associated liver disease. A narrative review. Alcoholism, clinical and experimental research. 2022; 46(12): 2149–2159. doi: 10.1111/acer.14967
  37. Kharbanda KK, Farokhnia M, Deschaine SL at al. Role of the ghrelin system in alcohol use disorder and alcohol-associated liver disease. A narrative review. Alcoholism, clinical and experimental research. 2022; 46(12): 2149–2159. doi: 10.1111/acer.14967
  38. Koob GF. Dynamics of neuronal circuits in addiction: reward, antireward and emotional memory. Pharmacopsychiatry. 2009; 42(10): 32-41
  39. Moore CF, Leonard MZ, Micovic NM et al. Reward sensitivity deficits in a rat model of compulsive eating behavior. Neuropsychopharmacol. 2020; 45: 589–596 doi: 10.1038/s41386-019-0550-1

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies